There are wide variations in the threshold used to define in vitro resistance of
Plasmodium falciparum
to amodiaquine (AQ), probably due to differences in methodology and interpretation. In vitro susceptibility data of Colombian
P. falciparum strains to AQ and N-desethylamodiaquine is used to illustrate the need to standardized methodologies and compare inhibitory concentrations, instead of resistant/susceptible phenotypes, when studying the mechanisms of resistance to AQ and monitoring drug susceptibility trends in the field.
